Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Wavegate
AddedFeb 16, 2024
UpdatedJun 18, 2026
Wavegate

Wavegate

Seed

Wavegate: Innovating in medical tech with a focus on neuromodulation and spinal cord stimulation for chronic pain.

HQ
Lake Charles, LA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Wavegate, founded with a mission to revolutionize medical technology, focuses on developing innovative solutions in neuromodulation. The company's core vision is to provide advanced treatments for chronic pain through its proprietary Spinal Cord Stimulation (SCS) technology. Their flagship product, the Ellipse TM Spinal Cord Stimulator Platform, leverages StimuLux TM Active Loop TM technology to offer effective pain relief for patients who have not found success with medications, physical therapy, or surgery.

Wavegate has garnered attention from notable figures in the medical technology field and has attracted significant investment to support its groundbreaking research and development. The company has achieved key milestones in advancing SCS technology, positioning itself as a leader in the treatment of chronic pain. Through its innovative products, Wavegate has made a substantial impact on improving the quality of life for patients suffering from debilitating pain conditions.

Wavegate - Similar Companies

Spine Wave logo

Spine Wave

spinewave.com

Micro-Leads logo

Micro-Leads

Wave Therapeutics logo

Wave Therapeutics

Spinex logo

Spinex

spinex.co

Gate Science logo

Gate Science

gatescience.com

ShiraTronics logo

ShiraTronics

shiratronics.com

Carewave Medical logo

Carewave Medical

Avivomed logo

Avivomed

avivomed.com

NeuraLace Medical logo

NeuraLace Medical

ARP Wave logo

ARP Wave

arpwave.com

StimAire logo

StimAire

stimaire.com

RBI Medical logo

RBI Medical

Hypersound Medical logo

Hypersound Medical

FastWave Medical logo

FastWave Medical

Spineloop logo

Spineloop

spineloop.com

Wavegate - Quick Facts

Who are Wavegate's competitors?

Companies similar to Wavegate include Spine Wave, Micro-Leads, Wave Therapeutics and Spinex.

When was Wavegate founded?

Wavegate was founded in 2019.

Where is Wavegate's headquarters located?

Wavegate's headquarters is located in Lake Charles, LA, US.

When was Wavegate's last funding round?

Wavegate's most recent funding round was for $2.4M (USD) in March 2023.

How much has Wavegate raised to-date?

As of Mar 22, 2023, Wavegate has raised a total of $2.4M (USD).

How many employees does Wavegate have?

Wavegate has 2 employees as of Feb 5, 2024.

Wavegate - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Neuromodulation
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified